![](img019.GIF) |
Why is a such difference between pharmaceutical companies
responses to insulin treated patients and patients with HIV or AIDS? The lobby of groups
with HIV is very powerful. Clearly AIDS is much more major health care and public health
problem than Type 1 diabetes. But reduction for insulin prices will not much reflect the
total profit of pharmaceutical companies! International community of diabetes health care
workers weak because of several reasons, as growing relationship between pharmaceutical
industry and the professionals, and because many major diabetes meetings are sponsored by
pharmaceutical companies. We see some lost of freedom to criticize of diabetes
organizations sponsored by industry. |